Select Page

DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) injection, for subcutaneous use

DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) injection, for subcutaneous use

DARZALEX FASPRO is a Anti Cancer medicine. DARZALEX FASPRO is used to treat multiple myeloma.
INDICATIONS AND USAGE

DARZALEX FASPRO is a combination of daratumumab, a CD38-directed cytolytic antibody, and hyaluronidase, an endoglycosidase, for the treatment of adult patients with multiple myeloma:
• in combination with bortezomib, melphalan and prednisone in newly diagnosed patients who are ineligible for autologous stem cell transplant.
• in combination with lenalidomide and dexamethasone in newly diagnosed patients who are ineligible for autologous stem cell transplant and in patients with relapsed or refractory multiple myeloma who have received at least one prior therapy.
• in combination with bortezomib and dexamethasone in patients who have received at least one prior therapy.
• as monotherapy, in patients who have received at least three prior lines of therapy including a proteasome inhibitor (PI) and an immunomodulatory agent or who are double-refractory to a PI and an immunomodulatory agent.
DOSAGE FORMS & STRENGTHS
Injection: 1,800 mg daratumumab and 30,000 units hyaluronidase per 15 mL (120 mg and 2,000 units/mL) solution in a single-dose vial.
Manufactured By: Janssen Biotech, Inc
Prescribing Information URL: Click Here

Procedure to buy DARZALEX FASPRO ™ (daratumumab and hyaluronidase-fihj) injection?
To buy DARZALEX FASPRO ™ (daratumumab and hyaluronidase-fihj) injection, patients can simply fill the order form or can send mail at info@bioniquehealthcare.com. or can also send Whatsapp message at +91 96677 50889. You will get reply within few hours with pricing and procedure details. Note:- the order will be confirmed only after the receipt of valid prescription of doctor.

Category:

Daratumumab/hyaluronidase is indicated for the treatment of adults with multiple myeloma:
• in combination with bortezomib, melphalan and prednisone (D-VMP) in newly diagnosed adults who are ineligible for autologous stem cell transplant
• in combination with lenalidomide and dexamethasone (D-Rd) in newly diagnosed adults who are ineligible for autologous stem cell transplant and in people with relapsed or refractory multiple myeloma who have received at least one prior therapy
• in combination with bortezomib and dexamethasone (D-Vd) in adults who have received at least one prior therapy as monotherapy, in adults who have received at least three prior lines of therapy including a proteasome inhibitor (PI) and an immunomodulatory agent or who are double-refractory to a PI and an immunomodulatory agent.
• It was approved for use in the United States in May 2020.

Documentation

  1. Doctor’s Prescription – We would require prescription from registered medical practitioner stating product name, dosage, duration of treatment and diagnosis.
  2. Patient’s Medical history – We would require all test reports and medical reports of the patient for last 3 months.
  3. Patient’s Identity card – We will require scan copy of patient’s identity card and proof of residence to initiate documentation process. you can use copy of passport, driving license, employee ID card or any photo id document as your identity card.

For Overseas Patient

Can I get anti-cancer medicines even if I am not based in India?

Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. The Bionique Healthcare can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your query to find the best price of –

DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) injection in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) injection in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) injection in North America – Mexico.
DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) injection in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) injection in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) injection in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) injection in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) injection in Australia and New Zealand.

For Indian Patient

Ani-Cancer DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) injection are prescription drug. 

We facilitate by-

  • Helping in documentation to import the medicine for personal use.
  • Finding Genuine and reliable source in USA, Europe and Japan.
  • Ensuring 100% transparency.

DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) injection can be shipped to Ahmedabad, Bangalore, Chennai, Cochin, Hyderabad, Delhi, Haryana, Jaipur, Jammu and Kashmir, Himachal Pradesh, Kolkata, Lucknow, Mumbai, Pune, Punjab and other cities in India. Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. 

Reviews

There are no reviews yet.

Be the first to review “DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) injection, for subcutaneous use”

Your email address will not be published. Required fields are marked *

Anti-Cancer Medicine Supplier.

Bionique Healthcare is a consulting pharmaceutical company which assist Patients in accessing medicines in India. Bionique Healthcare facilitates such access only against valid prescriptions in conformity with all local laws and regulations.

Patients/ Clinicians / Researchers can contact Bionique at +91 9667750889 or write to at – info@bioniquehealthcare.com.

Product Disclaimer

Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturer or licensee. 

Bionique Healthcare does not lay any claim on them.